These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30009843)

  • 1. Allograft rejection is associated with development of functional IgE specific for donor MHC antigens.
    Farkas AM; Baranyi U; Böhmig GA; Unger L; Hopf S; Wahrmann M; Regele H; Mahr B; Schwarz C; Hock K; Pilat N; Kristo I; Mraz J; Lupinek C; Thalhamer J; Bond G; Kuessel L; Wlodek E; Martin J; Clatworthy M; Pettigrew G; Valenta R; Wekerle T
    J Allergy Clin Immunol; 2019 Jan; 143(1):335-345.e12. PubMed ID: 30009843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods to Detect MHC-Specific IgE in Mice and Men.
    Weijler AM; Mucha J; Farkas AM; Baranyi U; Pilat N; Cho A; Muckenhuber M; Hopf S; Wahrmann M; Linhart B; Valenta R; Wekerle T
    Front Immunol; 2020; 11():586856. PubMed ID: 33363535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgM and IgG alloantibody responses to MHC class I and II following rat renal allograft rejection. Effects of transplantectomy and posttransplantation blood transfusion.
    Wray DW; Baldwin WM; Sanfilippo F
    Transplantation; 1992 Jan; 53(1):167-74. PubMed ID: 1370736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective assessment of pre-existing and
    Mucha J; Cho A; Weijler AM; Muckenhuber M; Hofmann AG; Wahrmann M; Heinzel A; Linhart B; Gattinger P; Valenta R; Berlakovich G; Zuckermann A; Jaksch P; Oberbauer R; Wekerle T
    Front Immunol; 2023; 14():1179036. PubMed ID: 37731514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation.
    Itescu S; Tung TC; Burke EM; Weinberg A; Moazami N; Artrip JH; Suciu-Foca N; Rose EA; Oz MC; Michler RE
    Circulation; 1998 Aug; 98(8):786-93. PubMed ID: 9727549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different patterns of sensitization following renal allograft rejection in an inbred rat strain combination.
    Wray DW; Baldwin WM; Sanfilippo F
    Transplantation; 1993 May; 55(5):1132-8. PubMed ID: 8497894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-donor MHC Class II Alloantibody Induces Glomerular Injury in Mouse Renal Allografts Subjected to Prolonged Cold Ischemia.
    Gorbacheva V; Fan R; Beavers A; Fairchild RL; Baldwin WM; Valujskikh A
    J Am Soc Nephrol; 2019 Dec; 30(12):2413-2425. PubMed ID: 31597715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presensitization by skin grafting from major histocompatibility complex class I or major histocompatibility complex class II deficient mice identifies class I antigens as inducers of allosensitization.
    Qian S; Fu F; Li Y; Gao L; Lu L; Noyola H; Rao AS; Thomson AW; Fung JJ
    Immunology; 1995 May; 85(1):82-7. PubMed ID: 7635525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts.
    Qian S; Fu F; Li Y; Lu L; Rao AS; Starzl TE; Thomson AW; Fung JJ
    Immunology; 1996 May; 88(1):124-9. PubMed ID: 8707337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies against MICA antigens and kidney-transplant rejection.
    Zou Y; Stastny P; Süsal C; Döhler B; Opelz G
    N Engl J Med; 2007 Sep; 357(13):1293-300. PubMed ID: 17898098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of donor-specific anti-HLA antibodies during episodes of renal allograft rejection.
    Supon P; Constantino D; Hao P; Cagle L; Hahn A; Conti DJ; Freed BM
    Transplantation; 2001 Feb; 71(4):577-80. PubMed ID: 11258441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered intragraft immune responses and improved renal function in MHC class II-deficient mouse kidney allografts.
    Mannon RB; Doyle C; Griffiths R; Bustos M; Platt JL; Coffman TM
    Transplantation; 2000 May; 69(10):2137-43. PubMed ID: 10852613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA.
    Solgi G; Furst D; Mytilineos J; Pourmand G; Amirzargar AA
    Transpl Immunol; 2012 Mar; 26(2-3):81-7. PubMed ID: 22182633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor-specific cellular immunity in rejecting and long-term-surviving class I-disparate rat renal allograft recipients.
    Ruiz P; Fuller J; Sanfilippo F
    Transplantation; 1990 Jan; 49(1):175-83. PubMed ID: 2301009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-mediated rejection of single class I MHC-disparate cardiac allografts.
    Hattori Y; Bucy RP; Kubota Y; Baldwin WM; Fairchild RL
    Am J Transplant; 2012 Aug; 12(8):2017-28. PubMed ID: 22578247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A significant role for anti-human leukocyte antigen antibodies and antibody-mediated rejection in the biopsy-for-cause population.
    Banasik M; Kościelska-Kasprzak K; Myszka M; Bartoszek D; Zabińska M; Boratyńska M; Kamińska D; Mazanowska O; Zmonarski S; Krajewska M; Hałoń A; Dawiskiba T; Nowakowska B; Klinger M
    Transplant Proc; 2014 Oct; 46(8):2613-7. PubMed ID: 25380878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of irreversible rejection in the presence of warm anti-donor-HLA class I cytotoxic IgG antibody.
    Shoker A; Klassen J; Herbut B
    Clin Nephrol; 1997 Feb; 47(2):87-91. PubMed ID: 9049455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathymic immunomodulation in sensitized rat recipients of cardiac allografts: requirements for allorecognition pathways.
    Stadlbauer TH; Schaub M; Magee CC; Kupiec-Weglinski JW; Sayegh MH
    J Heart Lung Transplant; 2000 Jun; 19(6):566-75. PubMed ID: 10867337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotoxin Against a Donor MHC Class II Molecule Induces Indefinite Survival of Murine Kidney Allografts.
    Brown K; Nowocin AK; Meader L; Edwards LA; Smith RA; Wong W
    Am J Transplant; 2016 Apr; 16(4):1129-38. PubMed ID: 26799449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation.
    Littera R; Piredda G; Argiolas D; Lai S; Congeddu E; Ragatzu P; Melis M; Carta E; Michittu MB; Valentini D; Cappai L; Porcella R; Alba F; Serra M; Loi V; Maddi R; Orrù S; La Nasa G; Caocci G; Cusano R; Arras M; Frongia M; Pani A; Carcassi C
    PLoS One; 2017; 12(7):e0180831. PubMed ID: 28686681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.